342 related articles for article (PubMed ID: 6601494)
1. Reactivity of bovine blood coagulation factor IXa beta, factor Xa beta, and factor XIa toward fluorogenic peptides containing the activation site sequences of bovine factor IX and factor X.
Castillo MJ; Kurachi K; Nishino N; Ohkubo I; Powers JC
Biochemistry; 1983 Mar; 22(5):1021-9. PubMed ID: 6601494
[TBL] [Abstract][Full Text] [Related]
2. Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates.
McRae BJ; Kurachi K; Heimark RL; Fujikawa K; Davie EW; Powers JC
Biochemistry; 1981 Dec; 20(25):7196-206. PubMed ID: 6976185
[TBL] [Abstract][Full Text] [Related]
3. Active-site mapping of bovine and human blood coagulation serine proteases using synthetic peptide 4-nitroanilide and thio ester substrates.
Cho K; Tanaka T; Cook RR; Kisiel W; Fujikawa K; Kurachi K; Powers JC
Biochemistry; 1984 Feb; 23(4):644-50. PubMed ID: 6370301
[TBL] [Abstract][Full Text] [Related]
4. Kinetic comparison of bovine blood coagulation factors IXa alpha and IXa beta toward bovine factor X.
Link RP; Castellino FJ
Biochemistry; 1983 Aug; 22(17):4033-41. PubMed ID: 6412750
[TBL] [Abstract][Full Text] [Related]
5. Small synthetic peptides with affinity for proteases in coagulation and fibrinolysis: an overview.
Claeson G; Aurell L
Ann N Y Acad Sci; 1981; 370():798-811. PubMed ID: 6455958
[No Abstract] [Full Text] [Related]
6. Intrinsic versus extrinsic coagulation. Kinetic considerations.
Warn-Cramer BJ; Bajaj SP
Biochem J; 1986 Nov; 239(3):757-62. PubMed ID: 3493767
[TBL] [Abstract][Full Text] [Related]
7. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J
J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737
[TBL] [Abstract][Full Text] [Related]
8. Activation of normal and abnormal human factor IX with trypsin.
Monroe DM; Noyes CM; Straight DL; Roberts HR; Griffith MJ
Arch Biochem Biophys; 1985 May; 238(2):490-6. PubMed ID: 3873217
[TBL] [Abstract][Full Text] [Related]
9. Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.
Ahmad SS; Wong MY; Rawala R; Jameson BA; Walsh PN
Biochemistry; 1998 Feb; 37(6):1671-9. PubMed ID: 9484238
[TBL] [Abstract][Full Text] [Related]
10. Assembly of the intrinsic factor X activating complex--interactions between factor IXa, factor VIIIa and phospholipid.
van Dieijen G; van Rijn JL; Govers-Riemslag JW; Hemker HC; Rosing J
Thromb Haemost; 1985 Jun; 53(3):396-400. PubMed ID: 3931288
[TBL] [Abstract][Full Text] [Related]
11. The contribution of Ca2+ and phospholipids to the activation of human blood-coagulation Factor X by activated Factor IX.
Mertens K; Bertina RM
Biochem J; 1984 Nov; 223(3):607-15. PubMed ID: 6334517
[TBL] [Abstract][Full Text] [Related]
12. The kinetic assembly of the intrinsic bovine factor X activation system.
Beals JM; Chibber BA; Castellino FJ
Arch Biochem Biophys; 1989 Feb; 268(2):485-501. PubMed ID: 2492418
[TBL] [Abstract][Full Text] [Related]
13. The role of phospholipid and factor VIIIa in the activation of bovine factor X.
van Dieijen G; Tans G; Rosing J; Hemker HC
J Biol Chem; 1981 Apr; 256(7):3433-42. PubMed ID: 6782101
[TBL] [Abstract][Full Text] [Related]
14. Cleavage at arginine 145 in human blood coagulation factor IX converts the zymogen into a factor VIII binding enzyme.
Lenting PJ; ter Maat H; Clijsters PP; Donath MJ; van Mourik JA; Mertens K
J Biol Chem; 1995 Jun; 270(25):14884-90. PubMed ID: 7797466
[TBL] [Abstract][Full Text] [Related]
15. The active site of antithrombin. Release of the same proteolytically cleaved form of the inhibitor from complexes with factor IXa, factor Xa, and thrombin.
Björk I; Jackson CM; Jörnvall H; Lavine KK; Nordling K; Salsgiver WJ
J Biol Chem; 1982 Mar; 257(5):2406-11. PubMed ID: 6977539
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil elastase cleavage of human factor IX generates an activated factor IX-like product devoid of coagulant function.
Samis JA; Kam E; Nesheim ME; Giles AR
Blood; 1998 Aug; 92(4):1287-96. PubMed ID: 9694717
[TBL] [Abstract][Full Text] [Related]
17. The binding of factor IXa to cultured bovine aortic endothelial cells. Induction of a specific site in the presence of factors VIII and X.
Stern DM; Nawroth PP; Kisiel W; Vehar G; Esmon CT
J Biol Chem; 1985 Jun; 260(11):6717-22. PubMed ID: 3922979
[TBL] [Abstract][Full Text] [Related]
18. Aminonaphthalenesulfonamides, a new class of modifiable fluorescent detecting groups and their use in substrates for serine protease enzymes.
Butenas S; Orfeo T; Lawson JH; Mann KG
Biochemistry; 1992 Jun; 31(23):5399-411. PubMed ID: 1606166
[TBL] [Abstract][Full Text] [Related]
19. Baculovirus-mediated expression of the epidermal growth factor-like modules of human factor IX fused to the factor XIIIa transamidation site in fibronectin. Evidence for a direct interaction between the NH2-terminal epidermal growth factor-like module of factor IXa beta and factor X.
Astermark J; Sottile J; Mosher DF; Stenflo J
J Biol Chem; 1994 Feb; 269(5):3690-7. PubMed ID: 7906269
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the P2' and P3' specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesis.
Le Bonniec BF; Myles T; Johnson T; Knight CG; Tapparelli C; Stone SR
Biochemistry; 1996 Jun; 35(22):7114-22. PubMed ID: 8679538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
